Introduction

The SRSLY NGS Library Prep Kit from ClaretBio offers an efficient and simplified solution for library preparation using a technology based on single-stranded DNA through a ligation method. Unlike traditional library preparations, which are based on double-stranded DNA, SRSLY kits allow the entire DNA of the initial sample to be transformed into a sequenceable library, even in samples with minimal amounts of DNA (250 pg) and degraded DNA (kits compatible with paraffin-extracted DNA, ancient DNA…). Additionally, this kit enables the generation of complex libraries in a very short time of ~2.5 hours.

Detailed Description

The SRSLY kit provides three bead purification options (retention of small, moderate, and large fragments), adapting to different types and sizes of starting DNA. Available in a modular format, it offers maximum flexibility for the user in the choice of base kit, reaction volume, bead purification, and the addition of unique molecular indices (UMI) or dual indices (UDI) during PCR amplification.

imagen 2024 07 17 125430394

Key Aspects

  • Fast and efficient: Preparation in 2.5 hours.
  • Versatility: Suitable for low starting amounts of DNA (such as cfDNA) and degraded DNA (ancient DNA, paraffin-extracted DNA).
  • Modularity: Allows customization according to project needs.
  • Bead purification: Three options for different fragment sizes.
  • UMI and UDI primers: For precise identification and reduction of PCR duplicates.
imagen 2024 07 17 125338135
imagen 2024 07 17 125147836

What the Kit includes

  • Base kit for 24 or 96 reactions.
  • UMI and UDI primer options.
  • Bead purification modules.
  • Detailed user manual and technical support.

Area:

Forensic Genetics, Solid tumor

Documents:

Consult our experts

Google reCaptcha: Invalid site key.

Related products

SureSelect Cancer CGP Assay

Targeted-enrichment NGS pan-cancer panel for comprehensive genomic profiling (CGP) of solid tumours. Designed to detect somatic variants at DNA level (SNVs, indels, CNVs, translocations) and RNA level (gene fusions), as well as to assess complex immuno-oncology biomarkers such as tumour mutational burden (TMB), microsatellite instability (MSI) and homologous recombination deficiency (HRD). Detailed Description Operating principle…
Agilent
Next Generation Sequencing (NGS)

SeqOne HRD Solution con Agilent SureSelect CD HRR17 Panel

HRD analysis solution combining low-coverage whole-genome sequencing (shallow/low-pass WGS) and a targeted gene panel to detect genomic instability, BRCA1/2 alterations and other genes related to homologous recombination. It is designed for laboratories wishing to implement HRD testing in-house with an automated, efficient and clinically validated workflow. Detailed Description SeqOne’s HRD solution combines shallow WGS and…
Agilent
Next Generation Sequencing (NGS)

OncoSELECT®

Comprehensive targeted liquid biopsy assay designed to support decision-making in oncology through the analysis of 74 clinically relevant genes. The solution encompasses everything from library preparation reagents to bioinformatics analysis, clinical interpretation and the generation of detailed reports. 3.- Detailed Description Operating principle OncoSELECT® is an advanced liquid biopsy panel based on circulating cell-free DNA…
OncoDNA
Next Generation Sequencing (NGS)

MSK-ACCESS® powered with SOPHiA DDM™

In-house liquid biopsy solution based on hybrid-capture next-generation sequencing (NGS) technology for the ultrasensitive detection of somatic alterations in circulating cell-free DNA from plasma. Developed in collaboration with Memorial Sloan Kettering Cancer Center (MSK), it implements a robust matched tumor-normal sequencing approach (plasma cfDNA + white blood cell DNA) to filter germline variants and mutations…
SOPHIA Genetics
Next Generation Sequencing (NGS)